Growth factors (GFs), chemokines, cytokines, and other signaling molecules all play a role in wound healing and tissue regeneration. Numerous breakthroughs in the subject have shed light on the mechanics of wound healing, and different technical solutions have been proposed as a result of these scientific advances. However, the mechanisms of tissue regeneration following wound injury have yet to be fully understood. Current advancements in unique drug delivery systems (DDSs) that release growth factors (GFs) offer a huge opportunity to develop new medicines or improve the efficacy of existing treatments. These breakthroughs are especially important in the field of regenerative medicine, which is tackling challenges like wound healing and skin restoration. To this purpose, biocompatible biomaterials have been intensively investigated in order to improve DDS in vivo integration, increase the bioactivity of released medications, and deliver bioactive compounds in a targeted and regulated manner.
Title : Side effect free cancer chemotherapy by directed gene delivery using nanomaterials
A C Matin, Stanford University School of Medicine, United States
Title : Artificial intelligence (AI) in biomedical engineering
Hossein Hosseinkhani, Innovation Center for Advanced Technology, Matrix HT, United States
Title : Novel gene therapy options for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : 30,000 nano implants in humans with no infections, no loosening, and no failures
Thomas J Webster, Hebei University of Technology, China
Title : Challenges in skeletal tissue engineering
Patrizia Ferretti, UCL Great Ormond Street Institute of Child Health, United Kingdom
Title : Electroactive polymer-based smart scaffolds for tissue engineering and regenerative medicine
Federico Carpi, University of Florence, Italy